Axsome Therapeutics, Inc. (AXSM)
207.33
-1.02
(-0.49%)
USD |
NASDAQ |
Sep 04, 11:31
Axsome Therapeutics Net Income (Annual) : -183.17M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -183.17M |
| December 31, 2024 | -287.22M |
| December 31, 2023 | -239.24M |
| December 31, 2022 | -187.13M |
| December 31, 2021 | -130.40M |
| December 31, 2020 | -102.90M |
| December 31, 2019 | -68.35M |
| Date | Value |
|---|---|
| December 31, 2018 | -30.97M |
| December 31, 2017 | -28.94M |
| December 31, 2016 | -27.20M |
| December 31, 2015 | -12.21M |
| December 31, 2014 | -6.001M |
| December 31, 2013 | -2.167M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Eli Lilly & Co. | 20.64B |
| Liquidia Corp. | -68.92M |
| Filana Therapeutics, Inc. | -90.97M |
| CorMedix, Inc. | 163.06M |
| Eloxx Pharmaceuticals, Inc. | -5.995M |